US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist
  • 14.610
  • -0.210-1.42%
Close Mar 20 16:00 ET
  • 14.610
  • 0.0000.00%
Post 16:20 ET
2.12BMarket Cap-5.68P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
204.74%330.53M
0
-64.40%1.27M
460.45%294.12M
-16.61%35.14M
Operating revenue
--0
--0
--0
--0
--0
214.60%330.53M
--0
588.59%1.27M
460.45%294.12M
-16.61%35.14M
Cost of revenue
Gross profit
Operating expense
-4.81%501.88M
-2.06%129.85M
7.06%123.19M
-5.70%116.59M
-15.20%132.25M
17.37%527.23M
14.65%132.57M
3.62%115.06M
8.56%123.64M
43.55%155.96M
Selling and administrative expenses
2.02%105.44M
21.36%30.06M
-1.48%24.95M
-3.55%25.19M
-7.02%25.24M
14.23%103.35M
5.33%24.77M
8.88%25.33M
23.45%26.12M
20.40%27.14M
-General and administrative expense
2.02%105.44M
21.36%30.06M
-1.48%24.95M
-3.55%25.19M
-7.02%25.24M
14.23%103.35M
5.33%24.77M
8.88%25.33M
23.45%26.12M
20.40%27.14M
Research and development costs
-6.47%396.44M
-7.44%99.79M
9.47%98.24M
-6.28%91.4M
-16.92%107.02M
18.16%423.88M
17.04%107.8M
2.22%89.74M
5.16%97.52M
49.62%128.82M
Operating profit
-155.15%-501.88M
2.06%-129.85M
-8.25%-123.19M
-168.39%-116.59M
-9.47%-132.25M
42.27%-196.7M
-25.85%-132.57M
-5.87%-113.8M
377.59%170.48M
-81.68%-120.82M
Net non-operating interest income expense
25.49%64.64M
15.48%15.16M
10.75%16M
36.18%17.57M
44.22%15.91M
248.62%51.51M
97.13%13.13M
244.92%14.44M
386.98%12.9M
763.38%11.03M
Non-operating interest income
25.49%64.64M
15.48%15.16M
10.75%16M
36.18%17.57M
44.22%15.91M
248.62%51.51M
--13.13M
--14.44M
386.98%12.9M
763.38%11.03M
Other net income (expense)
14.54M
0
14.54M
Special income (charges)
--14.54M
--0
--0
--0
--14.54M
--0
--0
--0
--0
--0
-Gain on sale of business
--14.54M
--0
--0
--0
--14.54M
--0
--0
--0
--0
--0
Income before tax
-191.13%-422.71M
3.98%-114.69M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.46%-145.19M
-21.04%-119.44M
3.82%-99.35M
412.05%183.38M
-68.32%-109.78M
Income tax
126.67%68K
42.86%30K
Net income
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
Net income continuous Operations
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
Minority interest income
Net income attributable to the parent company
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
Basic earnings per share
-142.45%-2.57
22.09%-0.67
12.50%-0.63
-144.03%-0.59
15.00%-0.68
59.23%-1.06
-14.67%-0.86
14.29%-0.72
379.17%1.34
-50.94%-0.8
Diluted earnings per share
-142.45%-2.57
22.09%-0.67
12.50%-0.63
-145.38%-0.59
15.00%-0.68
59.23%-1.06
-14.67%-0.86
14.29%-0.72
370.83%1.3
-50.94%-0.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 00000204.74%330.53M0-64.40%1.27M460.45%294.12M-16.61%35.14M
Operating revenue --0--0--0--0--0214.60%330.53M--0588.59%1.27M460.45%294.12M-16.61%35.14M
Cost of revenue
Gross profit
Operating expense -4.81%501.88M-2.06%129.85M7.06%123.19M-5.70%116.59M-15.20%132.25M17.37%527.23M14.65%132.57M3.62%115.06M8.56%123.64M43.55%155.96M
Selling and administrative expenses 2.02%105.44M21.36%30.06M-1.48%24.95M-3.55%25.19M-7.02%25.24M14.23%103.35M5.33%24.77M8.88%25.33M23.45%26.12M20.40%27.14M
-General and administrative expense 2.02%105.44M21.36%30.06M-1.48%24.95M-3.55%25.19M-7.02%25.24M14.23%103.35M5.33%24.77M8.88%25.33M23.45%26.12M20.40%27.14M
Research and development costs -6.47%396.44M-7.44%99.79M9.47%98.24M-6.28%91.4M-16.92%107.02M18.16%423.88M17.04%107.8M2.22%89.74M5.16%97.52M49.62%128.82M
Operating profit -155.15%-501.88M2.06%-129.85M-8.25%-123.19M-168.39%-116.59M-9.47%-132.25M42.27%-196.7M-25.85%-132.57M-5.87%-113.8M377.59%170.48M-81.68%-120.82M
Net non-operating interest income expense 25.49%64.64M15.48%15.16M10.75%16M36.18%17.57M44.22%15.91M248.62%51.51M97.13%13.13M244.92%14.44M386.98%12.9M763.38%11.03M
Non-operating interest income 25.49%64.64M15.48%15.16M10.75%16M36.18%17.57M44.22%15.91M248.62%51.51M--13.13M--14.44M386.98%12.9M763.38%11.03M
Other net income (expense) 14.54M014.54M
Special income (charges) --14.54M--0--0--0--14.54M--0--0--0--0--0
-Gain on sale of business --14.54M--0--0--0--14.54M--0--0--0--0--0
Income before tax -191.13%-422.71M3.98%-114.69M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.46%-145.19M-21.04%-119.44M3.82%-99.35M412.05%183.38M-68.32%-109.78M
Income tax 126.67%68K42.86%30K
Net income -191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M
Net income continuous Operations -191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M
Minority interest income
Net income attributable to the parent company -191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M
Basic earnings per share -142.45%-2.5722.09%-0.6712.50%-0.63-144.03%-0.5915.00%-0.6859.23%-1.06-14.67%-0.8614.29%-0.72379.17%1.34-50.94%-0.8
Diluted earnings per share -142.45%-2.5722.09%-0.6712.50%-0.63-145.38%-0.5915.00%-0.6859.23%-1.06-14.67%-0.8614.29%-0.72370.83%1.3-50.94%-0.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Taiwan Semiconductor
TSM
+2.14%
NVIDIA
NVDA
+0.86%
Advanced Micro Devices
AMD
+0.86%
Adobe
ADBE
+0.44%
Meta Platforms
META
+0.33%

Unlock the Full List